Proulx K., Clavel S., Nault G., Richard D., Walker C. (2001). High neonatal leptin exposure enhances brain GR expression and feedback efficacy on the adrenocortical axis of developing rats, Endocrinology, 142(11), 4607-16.

Redko C., Legault L., Brown T., Dongier M. (2001). Deux expériences québécoises d'évaluation à long terme du traitement des addictions . In Brochu S., Guyon L., Landry M. & Brochu S. (Eds.) , Impact du traitement en alcoolisme et toxicomanie : études québécoises (pp. 1-15). Presses de l'Université Laval.

Roberts A. J., Gold L. H., Polis I., McDonald J. S., Filliol D., Kieffer B., Koob G. F. (2001). Increased ethanol self-administration in delta-opioid receptor knockout mice, Alcohol Clin Exp Res, 25(9), 1249-56. Find out more.

Sarton E., Teppema L. J., Olievier C., Nieuwenhuijs D., Matthes H. W., Kieffer B., Dahan A. (2001). The involvement of the mu-opioid receptor in ketamine-induced respiratory depression and antinociception, Anesth Analg, 93(6), 1495-500, table of contents. Find out more.

Shoulson I., Penney J., McDermott M., Schwid S., Kayson E., Chase T., Fahn S., Greenamyre J. T., Lang A., Siderowf A., Pearson N., Harrison M., Rost E., Colcher A., Lloyd M., Matthews M., Pahwa R., McGuire D., Lew M. F., Schuman S., Marek K., Broshjeit S., Factor S., Brown T., Feigin A., Mazurkiewicz J., Ford B., Jennings D., Dilllon S., Comella C., Blasucci L., Janko K., Shulman L., Wiener W., Bateman-Rodriguez D., Carrion A., Suchowersky O., Lafontaine A. L., Pantella C., Siemers E., Belden J., Davies R., Lannon M., Grimes D., Gray P., Martin W., Kennedy L., Adler C., Newman S., Hammerstad J., Stone C., Lewitt P., Bardram K., Mistura K., Miyasaki J., Johnston L., Cha J. H., Tennis M., Panniset M., Hall J., Tetrud J., Friedlander J., Hauser R., Gauger L., Rodnitzky R., Deleo A., Dobson J., Seeberger L., Dingmann C., Tarsy D., Ryan P., Elmer L., Ruzicka D., Stacy M., Brewer M., Locke B., Baker D., Casaceli C., Day D., Florack M., Hodgeman K., Laroia N., Nobel R., Orme C., Rexo L., Rothenburgh K., Sulimowicz K., Watts A., Wratni E., Tariot P., Cox C., Leventhal C., Alderfer V., Craun A. M., Frey J., McCree L., McDermott J., Cooper J., Holdich T., Read B. (2001). A randomized, controlled trial of remacemide for motor fluctuations in Parkinson's disease, Neurology, 56(4), 455-62.

Simonin F., Slowe S., Becker J. A., Matthes H. W., Filliol D., Chluba J., Kitchen I., Kieffer B. (2001). Analysis of [3H]bremazocine binding in single and combinatorial opioid receptor knockout mice, Eur J Pharmacol, 414(2-3), 189-95. Find out more.

Skoubis P. D., Matthes H. W., Walwyn W. M., Kieffer B., Maidment N. T. (2001). Naloxone fails to produce conditioned place aversion in mu-opioid receptor knock-out mice, Neuroscience, 106(4), 757-63. Find out more.

Slowe S. J., Clarke S., Lena I., Goody R. J., Lattanzi R., Negri L., Simonin F., Matthes H. W., Filliol D., Kieffer B., Kitchen I. (2001). Autoradiographic mapping of the opioid receptor-like 1 (ORL1) receptor in the brains of mu-, delta- or kappa-opioid receptor knockout mice, Neuroscience, 106(3), 469-80. Find out more.

Steiger H., Gauvin L., Israel M., Koerner N., Ng Ying Kin N. M., Paris J., Young S. N. (2001). Association of serotonin and cortisol indices with childhood abuse in bulimia nervosa, Arch Gen Psychiatry, 58(9), 837-43.

Steiger H., Koerner N., Engelberg M. J., Israel M., Ng Ying Kin N. M., Young S. N. (2001). Self-destructiveness and serotonin function in bulimia nervosa, Psychiatry Res, 103(1), 15-26.

Steiger H., Young S. N., Kin N. M., Koerner N., Israel M., Lageix P., Paris J. (2001). Implications of impulsive and affective symptoms for serotonin function in bulimia nervosa, Psychol Med, 31(1), 85-95.

Turecki G. (2001). Suicidal behavior: is there a genetic predisposition?, Bipolar Disord, 3(6), 335-49.

Turecki G., Briere R., Dewar K., Seguin M., Chawky N., et al. (2001). Dr. Turecki and colleagues reply, Am J Psychiatry, 158(1), 148.

Turecki G., Grof P., Grof E., D'Souza V., Lebuis L., Marineau C., Cavazzoni P., Duffy A., Betard C., Zvolsky P., Robertson C., Brewer C., Hudson T. J., Rouleau G. A., Alda M. (2001). Mapping susceptibility genes for bipolar disorder: a pharmacogenetic approach based on excellent response to lithium, Mol Psychiatry, 6(5), 570-8.

Turecki G., Zhu Z., Tzenova J., Lesage A., Seguin M., Tousignant M., Chawky N., Vanier C., Lipp O., Alda M., Joober R., Benkelfat C., Rouleau G. A. (2001). TPH and suicidal behavior: a study in suicide completers, Mol Psychiatry, 6(1), 98-102.

Van Ameringen M. A., Lane R. M., Walker C., Bowen R. C., Chokka P. R., Goldner E. M., Johnston D. G., Lavallee Y. J., Nandy S., Pecknold J. C., Hadrava V., Swinson R. P. (2001). Sertraline treatment of generalized social phobia: a 20-week, double-blind, placebo-controlled study, Am J Psychiatry, 158(2), 275-81.

Vedantham K., Brunet A., Boyer R., Weiss D. S., Metzler T. J., Marmar C. R. (2001). Posttraumatic stress disorder, trauma exposure, and the current health of Canadian bus drivers, Can J Psychiatry, 46(2), 149-55.

Walker C., Anand K. J. S., Plotsky P. M. (2001). Development of the Hypothalamus-Pituitary-Adrenal Axis and the Stress Response . In McEwen B. S. (Ed.) , Handbook of Physiology - Section 7: The Endocrine System. Volume IV: Coping with the Environment: Neural and Endocrine Mechanisms (pp. 237-270). Oxford University Press.

Walker C., Tilders F. J., Burlet A. (2001). Increased colocalization of corticotropin-releasing factor and arginine vasopressin in paraventricular neurones of the hypothalamus in lactating rats: evidence from immunotargeted lesions and immunohistochemistry, J Neuroendocrinol, 13(1), 74-85.

Walker C., Toufexis D. J., Burlet A. (2001). Hypothalamic and limbic expression of CRF and vasopressin during lactation: implications for the control of ACTH secretion and stress hyporesponsiveness, Prog Brain Res, 133, 99-110.